Market revenue in 2023 | USD 34.6 million |
Market revenue in 2030 | USD 41.3 million |
Growth rate | 2.6% (CAGR from 2023 to 2030) |
Largest segment | Stimulants |
Fastest growing segment | Non-stimulants |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stimulants, Non-stimulants |
Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 71.1% in 2023. Horizon Databook has segmented the UAE attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in government initiatives undertaken to support patients with ADHD is projected to drive the market. For instance, in 2020, the Dubai Health Authority (DHA) introduced specialized primary healthcare clinics for children with ADHD to provide quality care for various neurobiological disorders. Such initiatives are anticipated to drive the market.
Currently, the UAE is stockpiling ADHD medicines such as Strattera, Ritalin, and Concerta due to concern over a shortage of drugs. Concerta is the most prescribed ADHD medicine in the UAE due to wide availability and ease of source, it costs nearly USD 54.45. On the other hand, Ritalin is possibly the most difficult to obtain in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE attention deficit hyperactivity disorder market , including forecasts for subscribers. This country databook contains high-level insights into UAE attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account